Navigation Links
Liver Cancer Drug Raises Blood Pressure
Date:1/22/2008

Patients taking Nexavar need to be monitored closely, study says

TUESDAY, Jan. 22 (HealthDay News) -- A drug that prolongs the lives of patients with kidney or liver cancer also increases the risk of developing high blood pressure.

Patients taking Nexavar (sorafenib) need to be carefully monitored and treated, said the authors of a study appearing in the Jan. 22 online issue of Lancet Oncology.

Nexavar is an anti-angiogenesis drug, meaning it fights cancer by cutting off a tumor's blood supply.

It was approved in 2005 to treat advanced kidney cancer and in 2007 to treat the most common form of liver cancer that can't be surgically removed (unresectable hepatocellular carcinoma or HCC).

In clinical testing, Nexavar improved overall survival by 44 percent among people with HCC. Median overall survival was 10.7 months among those treated with the drug, versus 7.9 months among those who took a placebo. This was considered a major inroad against one of the most voracious cancers.

Nexavar is also being assessed to treat small-cell lung cancer, prostate cancer and melanoma.

Earlier trials, however, had shown a 16 percent to 42.6 percent incidence of hypertension in patients taking the drug. If not properly controlled, hypertension can lead to strokes and heart attacks, as well as kidney failure.

For this paper, researchers at the State University of New York Stony Brook conducted a meta-analysis of published clinical trials on Nexavar.

In all, nine studies involving 4,599 patients published between January 2006 and July 2007 were analyzed.

There was a 23.4 percent incidence of all-grade hypertension, and a 5.7 percent incidence of high-grade hypertension.

This is not the first time hypertension has been associated with an angiogenesis inhibitor. Several other drugs in this category, including Avastin (bevacizumab) and Sutent (sunitinib), have also raised blood pressure in patients.

More information

Visit the American Cancer Society for more on liver cancer.



-- Amanda Gardner



SOURCE: Lancet Oncology, news release, Jan. 21, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Struggling Medical Delivery System Impacts Hospitals and Physicians Hardest
2. Indian medicinal plant Acanthus ilicifolius may combat liver cancer
3. An emerging candidate for protecting patients from liver injury after abdomen surgery
4. March of Dimes Delivers a New Look
5. Engaging 2008 Debate, Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nations Long Term and Post-Acute Care Delivery System
6. Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions
7. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
8. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
9. EHE International Supports the American Liver Foundations Efforts at Raising Awareness for Hepatitis
10. High-energy ultrasound sharpens view of liver tumors
11. Treatment with NAC is associated with better outcomes for children with liver failure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Liver Cancer Drug Raises Blood Pressure
(Date:9/9/2019)... MONROE, Conn. (PRWEB) , ... September 09, 2019 ... ... celebrates 30 years of serving Monroe, CT with advanced gum disease treatment ... at the forefront of innovative technology, providing the most cutting-edge treatment available for ...
(Date:9/8/2019)... ... ... Stetson University ranks No. 5 on U.S. News & World Report’s ... Stetson appears on five additional lists in the same category: Best Undergraduate Teaching, No. ... No. 34; and a new list this year, Top Performers on Social Mobility, No. ...
(Date:9/8/2019)... Calif. (PRWEB) , ... September 06, 2019 , ... The ... tremendously positive! The high success rate for this non-invasive and pain free fat loss ... lose the unwanted fat in problem areas. , Contoura uses state of the art ...
(Date:9/8/2019)... ... 07, 2019 , ... Messaging Architects, an eMazzanti Technologies Company ... successful GroupWise to Office 365 email migration on the Messaging Architects website. The ... organization. , The informative article discusses the tight timeline faced by the Messaging ...
(Date:9/4/2019)... ... 2019 , ... Dental portal DrBicuspid.com, part of Science and Medicine Group, has ... prepare for the new 2020 Integrated National Board Dental Exam (INBDE). Dental Exam is ... must pass a board certification exam in order to become licensed to practice dentistry ...
Breaking Medicine News(10 mins):
(Date:9/11/2019)... NASHVILLE, Tenn. (PRWEB) , ... September 11, 2019 ... ... addition of Jeff Maris to lead its Cerner Strategic Implementation and Partnerships ... delivery as a Technology Sales Executive who expanded Cerner’s CareAware business and as ...
(Date:9/9/2019)... ... September 09, 2019 , ... New ... Dental Implants host the latest course in their Synergy Study Club, called “Truth ... features guest speaker Dr. Peter Barndt. Synergy Study Club brings together leading specialists ...
(Date:9/9/2019)... ... 09, 2019 , ... Dr. Jin Kim of Garden Grove, ... in Tilburg, Netherlands. A dual-board certified periodontist, Dr. Kim spoke about the application ... periodontics. At his practices in Diamond Bar and Garden Grove, CA, Dr. Kim ...
Breaking Medicine Technology: